期刊文献+

双抗体夹心ELISA测定人广泛型线粒体肌酸激酶方法的建立 被引量:4

Establishment of double antibody sandwich ELISA for the determination of human ubiquitous mitochondrial creatine kinase
下载PDF
导出
摘要 目的建立测定人血清广泛型线粒体肌酸激酶(uMtCK)浓度的双抗体夹心酶联免疫吸附试验(ELISA)。方法应用原核表达的uMtCK重组蛋白免疫小鼠获得7株单克隆抗体,采用棋盘格滴定法筛选出最佳双抗体组合,其中抗体19F11进行辣根过氧化物酶(HRP)标记作为检测抗体,抗体3C1作为俘获抗体,建立检测人uMtCK双抗体夹心ELISA方法,并进行方法学评价。同时采用该法检测50名健康体检者和85例肿瘤标志物[甲胎蛋白(AFP)或癌胚抗原(CEA)]阳性患者的血清。结果通过筛查获得配对抗体,建立检测人uMtCK的双抗体夹心ELISA方法。该法的检测限为28.8 ng/mL,批内变异系数(CV)为4.5%~7.7%,批间CV为8.2%~13.5%,平均回收率为97.1%。用该法检测50名健康体检者血清uMtCK浓度,结果均为阴性;85例肿瘤标志物阳性患者中有15例检出uMtCK,浓度为52.8~1 442.2 ng/mL。结论建立的双抗体夹心ELISA可以用于测定人血清uMtCK浓度。 Objective To establish double antibody sandwich enzyme-linked immunosorbent assay (ELISA) for the determination of ubiquitous mitochondrial creatine kinase (uMtCK) in human serum. Methods Seven strains of monoclonal antibodies against human uMtCK were prepared with prokaryotic expression recombinant proteins from rats, and the best combination of double antibodies was selected by checkerboard titration method. Double antibody sandwich ELISA for the determination of human uMtCK was established by using HRP-labeled McAb 19Fll as a detection antibody and McAb 3C1 as a capture antibody. The methodology performance was evaluated. The serum concentrations of uMtCK in 50 healthy subjects and 85 patients with positive tumor markers [ alpha fetal protein (AFP) and carcinoembryonic antigen (CEA)] were determined. Results The double antibody sandwich ELISA for the determination of human uMtCK was established by selecting the combination of double antibodies. The detection limit was 28.8ng/mL, and the within-run and between-run coefficients of variation (CV) were 4.5% -7.7% and 8.2% - 13. 5% , respectively. The average recovery was 97. 1%. The serum concentrations of uMtCK in 50 healthy subjects were negative. The 15 of 85 patients with positive tumor markers had positive results of uMtCK, and the concentration was 52.8 - 1 442.2 ng/mL. Conclusions The established double antibody sandwich ELISA can be used to determine uMtCK in human serum.
出处 《检验医学》 CAS 2013年第10期913-916,共4页 Laboratory Medicine
基金 上海市卫生局科研课题(2007068)
关键词 线粒体肌酸激酶 广泛型亚型 酶联免疫吸附试验 Mitochondrial creatine kinase Ubiquitous subtype Enzyme-linked immunosorbent assay
  • 相关文献

参考文献8

  • 1Schlattner U, Tokarska-Schlattner M, Wallimann T.Mitochondrial creatine kinase in human health and disease [ J ]. Biochim Biophys Acta, 2006,1762 ( 2 ) : 164-180. 被引量:1
  • 2Kanemitsu F, Kawanishi I, Mizushima J, et al. Mito- chondrial creatine kinase as a tumor-associated marker [J]. Clin Chim Acta, 1984, 138(2) :175-183. 被引量:1
  • 3Pratt R, Vallis LM, Lim CW, et al. Mitochondrial creatine kinase in cancer patients [ J ]. Pathology, 1987, 19(2) :162-165. 被引量:1
  • 4Lee YC, Chang K J, Lu FJ, et al. Serum macro creatine kinase type 2 as a tumor marker in lung cancer: comparison with carcinoembryonic antigen [J]. J Formos Med Assoc, 1990, 89(2) :104-109. 被引量:1
  • 5Kornacker M, Schlattner U, Wallimann T, et al. Hodgkin disease-derived cell lines expressing ubiqui- tous mitochondrial creatine kinase show growth inhibi- tion by cyclocreatine treatment independent of apopto- sis[J]. Int J Cancer, 2001,94(4) :513-519. 被引量:1
  • 6Qian XL, Li YQ, Gu F, et al. Overexpression of ubiquitous mitochondrial creatine kinase (uMtCK) accelerates tumor growth by inhibiting apoptosis of breast cancer cells and is associated with a poor prog- nosis in breast cancer patients [ J ]. Biochem Biophys Res Commun,2012,427( 1 ) :60-66. 被引量:1
  • 7张建,王爱华,顾鹏飞,于嘉屏.人线粒体肌酸激酶广泛型亚型的原核表达、抗体制备及其临床应用意义[J].第二军医大学学报,2004,25(12):1320-1324. 被引量:4
  • 8Hatano E, Tanaka A, Kanazawa A, et al. Inhibition of tumor necrosis factor-induced apoptosis in trans- genic mouse liver expressing creatine kinase [ J ]. Liver Int,2004,24 (4) :384-393. 被引量:1

二级参考文献13

  • 1[1]Wyss M,Smeitink J,Wevers RA,et al. Mitochondrial creatine kinase:a key enzyme of aerobic energy metabolism[J]. Biochim Biophys Acta,1992,1102(2):119-166. 被引量:1
  • 2[2]Schlegel J, Wyss M, Schurch U,et al. Mitochondrial creatine kinase from cardiac muscle and brain are two distinct isoenzymes but both form octameric molecules[J]. J Biol Chem,1988,263 (32):16963-16969. 被引量:1
  • 3[3]Crompton M. The mitochondrial permeability transition pore and its role in cell death[J]. Biochem J,1999,341(Pt 2):233-249. 被引量:1
  • 4[4]Lu CD,Altieri DC,Tanigawa N. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas [J]. Cancer Res,1998,58(9):1808-1812. 被引量:1
  • 5[5]Haas RC,Korenfeld C,Zhang ZF,et al. Isolation and characterization of the gene and cDNA encoding human mitochondrial creatine kinase[J]. J Biol Chem, 1989,264(5):2890-2897. 被引量:1
  • 6[6]Kaldis P,Furter R,Wallimann T. The N-terminal heptapeptide of mitochondrial creatine kinase is important for octamerization [J]. Biochemistry, 1994,33(4): 952-959. 被引量:1
  • 7[7]Kanemitsu F, Kawanishi I, Mizushima J, et al. Mitochondrial creatine kinase as a tumor associated marker[J]. Clin Chim Acta, 1984,138(2): 175-183. 被引量:1
  • 8[8]Martin KJ,Chen SF,Clark GM,et al. Evaluation of creatine analogues as a new class of anticancer agents using freshly explanted human tumor cells [J]. J Natl Cancer Inst, 1994, 86(8) :608-613. 被引量:1
  • 9[9]Pratt R,Vallis LM,Lim CW,et al. Mitochondrial creatine kinase in cancer patients[J]. Pathology, 1987,19 (2): 162-165. 被引量:1
  • 10[10]Schiemann S,Schwirzke M,Brunner N,et al. Molecular analysis of two mammary carcinoma cell lines at the transcriptionallevel as a model system for progression of breast cancer[J].Clin Exp Metastasis, 1998,16(2 ): 129-139. 被引量:1

共引文献3

同被引文献23

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部